Update on the use of immunoglobulin in human disease: A review of evidence

Affiliations

¹ Allergy Associates of the Palm Beaches, North Palm Beach, Fla. Electronic address: eperez@pballergy.com.
² Department of Pediatrics, Section of Immunology Allergy and Rheumatology, Center for Human Immunobiology, Texas Children's Hospital and Baylor College of Medicine, Houston, Tex.
³ Department of Pediatrics, Clinical Immunology Program, Children's Hospital Boston and Harvard Medical School, Boston, Mass.
⁴ Department of Pediatrics, Allergy, Immunology and BMT Division, Benioff Children's Hospital and University of California, San Francisco, Calif.
⁵ Department of Pediatrics, Pediatric Allergy and Immunology Unit, Children's Hospital and Ain Shams University, Cairo, Egypt.
⁶ Departments of Pathology and Laboratory Services and Pediatrics, University of Arkansas, Little Rock, Ark.
⁷ Department of Pediatrics, Allergy and Immunology, Montreal Children's Hospital and McGill University, Montreal, Quebec, Canada.
⁸ Department of Medicine and Pediatrics, Division of Hematology and Oncology and Stem Cell Transplantation, Riley Hospital, Indiana University School of Medicine and the IU Melvin and Bren Simon Cancer Center, Indianapolis, Ind.
⁹ Department of Pediatrics, Wayne State University, Children's Hospital of Michigan, Detroit, Mich.
¹⁰ Nephrology & Transplant Immunology, Kidney Transplant Program, David Geffen School of Medicine at UCLA and Cedars-Sinai Medical Center, Los Angeles, Calif.
¹¹ Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, Calif.
¹² Transplant Immunotherapy Program, Comprehensive Transplant Center, Kidney Transplant Program, Cedars-Sinai Medical Center, Los Angeles, Calif.
¹³ Department of Pediatrics, Division of Allergy & Immunology, University of South Florida, Morsani College of Medicine, Johns Hopkins All Children's Hospital, St Petersburg, Fla.

PMID: 28041678
DOI: 10.1016/j.jaci.2016.09.023

Review

Update on the use of immunoglobulin in human disease: A review of evidence

Elena E Perez et al. J Allergy Clin Immunol. 2017 Mar.

. 2017 Mar;139(3S):S1-S46.

doi: 10.1016/j.jaci.2016.09.023. Epub 2016 Dec 29.

Authors

Affiliations

¹ Allergy Associates of the Palm Beaches, North Palm Beach, Fla. Electronic address: eperez@pballergy.com.
² Department of Pediatrics, Section of Immunology Allergy and Rheumatology, Center for Human Immunobiology, Texas Children's Hospital and Baylor College of Medicine, Houston, Tex.
³ Department of Pediatrics, Clinical Immunology Program, Children's Hospital Boston and Harvard Medical School, Boston, Mass.
⁴ Department of Pediatrics, Allergy, Immunology and BMT Division, Benioff Children's Hospital and University of California, San Francisco, Calif.
⁵ Department of Pediatrics, Pediatric Allergy and Immunology Unit, Children's Hospital and Ain Shams University, Cairo, Egypt.
⁶ Departments of Pathology and Laboratory Services and Pediatrics, University of Arkansas, Little Rock, Ark.
⁷ Department of Pediatrics, Allergy and Immunology, Montreal Children's Hospital and McGill University, Montreal, Quebec, Canada.
⁸ Department of Medicine and Pediatrics, Division of Hematology and Oncology and Stem Cell Transplantation, Riley Hospital, Indiana University School of Medicine and the IU Melvin and Bren Simon Cancer Center, Indianapolis, Ind.
⁹ Department of Pediatrics, Wayne State University, Children's Hospital of Michigan, Detroit, Mich.
¹⁰ Nephrology & Transplant Immunology, Kidney Transplant Program, David Geffen School of Medicine at UCLA and Cedars-Sinai Medical Center, Los Angeles, Calif.
¹¹ Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, Calif.
¹² Transplant Immunotherapy Program, Comprehensive Transplant Center, Kidney Transplant Program, Cedars-Sinai Medical Center, Los Angeles, Calif.
¹³ Department of Pediatrics, Division of Allergy & Immunology, University of South Florida, Morsani College of Medicine, Johns Hopkins All Children's Hospital, St Petersburg, Fla.

PMID: 28041678
DOI: 10.1016/j.jaci.2016.09.023

Abstract

Human immunoglobulin preparations for intravenous or subcutaneous administration are the cornerstone of treatment in patients with primary immunodeficiency diseases affecting the humoral immune system. Intravenous preparations have a number of important uses in the treatment of other diseases in humans as well, some for which acceptable treatment alternatives do not exist. We provide an update of the evidence-based guideline on immunoglobulin therapy, last published in 2006. Given the potential risks and inherent scarcity of human immunoglobulin, careful consideration of its indications and administration is warranted.

Keywords: IGIV; IVIG; Immune globulin; SCIG; adverse events; autoimmunity; immune modulating; immunoglobulin; immunomodulation; primary immunodeficiency; transfusion.

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- ClinicalTrials.gov

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Update on the use of immunoglobulin in human disease: A review of evidence

Affiliations

Update on the use of immunoglobulin in human disease: A review of evidence

Authors

Affiliations

Abstract

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical